SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-22-000886
Filing Date
2022-04-15
Accepted
2022-04-15 17:05:33
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K axim_10k.htm 10-K 1700893
2 DESCRIPTION OF SECURITIES axim_ex41.htm EX-4.1 35099
3 BINDING TERM SHEET AGREEMENT axim_ex107.htm EX-10.7 25895
4 ASSET PURCHASE AGREEMENT axim_ex108.htm EX-10.8 67530
5 TERMINATION AGREEMENT axim_ex1012.htm EX-10.12 9896
6 SUBSIDIARIES axim_ex211.htm EX-21.1 1127
7 CONSENT axim_ex231.htm EX-23.1 2599
8 CERTIFICATION axim_ex311.htm EX-31.1 12036
9 CERTIFICATION axim_ex312.htm EX-31.2 12149
10 CERTIFICATION axim_ex321.htm EX-32.1 4623
11 CERTIFICATION axim_ex322.htm EX-32.2 4694
12 axim_10kimg1.jpg GRAPHIC 4231
13 axim_ex1012img2.jpg GRAPHIC 18367
14 axim_ex108img4.jpg GRAPHIC 10184
15 axim_ex108img3.jpg GRAPHIC 10583
16 axim_ex108img2.jpg GRAPHIC 18368
17 axim_ex108img1.jpg GRAPHIC 3722
  Complete submission text file 0001096906-22-000886.txt   1968606
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54296 | Film No.: 22830552
SIC: 2834 Pharmaceutical Preparations